Vela Diagnostics is always ready to foster long-term relationships with industry counterparts to achieve higher levels of innovation that leverage combined expertise.
By working closely with pharmaceutical and biotechnological companies, Vela Diagnostics can provide specialized knowledge in molecular diagnostics and companion diagnostics to help achieve efficiency in pharmaceutical development, regulatory approval and global commercialization.
To reap mutual benefits and rewards, Vela Diagnostics firmly believes in unique business models that suit the growth of partners.
Vela Diagnostics’ processes, manufacturing and quality system in Singapore are ISO 13485:2003 certified, and the R&D laboratory in the United States is CLIA-certified. From resource allocation to project communications to joint marketing, work processes are well established so that any partner can rely on us to deliver optimal outcomes.
For technology development Vela Diagnostics endeavors to deliver efficiency in all phases of the pharmaceutical life cycle, from pre-clinical planning to commercialization.
Working with an experienced management team and global talents overseeing R&D, manufacturing and aspects of commercial operations, partners can expect a high degree of professionalism in jointly exploring real-time PCR and Next-Generation Sequencing technologies.
To explore pharma partnering with Vela Diagnostics, please email us at firstname.lastname@example.org.